• 1
    American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society; 2007.
  • 2
    GreeneFL,PageDL,FlemingID, et al., eds. AJCC cancer staging manual, 6th ed. New York: Springer; 2002.
  • 3
    Fisher B,Wolmark N,Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988; 80: 2129.
  • 4
    Sauer R,Becker H,Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 17311740.
  • 5
    Bujko K,Nowacki MP,Nasierowska-Guttmejer A,Michalski W,Bebenek M,Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006; 93: 12151223.
  • 6
    Bosset J-F,Collette L,Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; 355: 11141123.
  • 7
    Gerard JP,Conroy T,Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006; 24: 46204625.
  • 8
    Grann A,Minsky BD,Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum. 1997; 40: 515522.
  • 9
    Guillem JG,Chessin DB,Cohen AM, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg. 2005; 241: 829836.
  • 10
    Meterissian S,Skibber J,Rich T, et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol. 1994; 1: 111116.
  • 11
    Garcia-Aguilar J,Hernandez de Anda E,Sirivongs P,Lee SH,Madoff RD,Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003; 46: 298304.
  • 12
    Mohiuddin M,Hayne M,Regine WF, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys. 2000; 48: 10751080.
  • 13
    Theodoropoulos G,Wise WE,Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum. 2002; 45: 895903.
  • 14
    Rodel C,Martus P,Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005; 23: 86888696.
  • 15
    Roh MS,Colangelo L,Wieand S, et al. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. J Clin Oncol (Meeting Abstracts). 2004; 22: 3505.
  • 16
    Nagtegaal ID,Gosens MJ,Marijnen CA,Rutten HJ,van de Velde CJ,van Krieken JH. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol. 2007; 25: 16471650.
  • 17
    Skibber JMHP,Minsky BD. Cancer of the rectum. In: DeVitaVT,RosenbergSA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2001: 3235.
  • 18
    Enker WE,Thaler HT,Cranor ML,Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995; 181: 335346.
  • 19
    Heald RJ,Moran BJ,Ryall RD,Sexton R,MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998; 133: 894899.
  • 20
    Ruo L,Tickoo S,Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002; 236: 7581.
  • 21
    Shia J,Guillem JG,Moore HG, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol. 2004; 28: 215223.
  • 22
    Gonen M,Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005; 92: 965970.
  • 23
    Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997; 336: 980987.
  • 24
    Bosset JF,Calais G,Mineur L, et al. Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol. 2005; 23: 56205627.
  • 25
    Collette L,Bosset JF,den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol. 2007; 25: 43794386.
  • 26
    Dworak O,Keilholz L,Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12: 1923.
  • 27
    Wheeler JM,Warren BF,Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum. 2002; 45: 10511056.
  • 28
    Vecchio FM,Valentini V,Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys. 2005; 62: 752760.
  • 29
    Mandard AM,Dalibard F,Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994; 73: 26802686.
  • 30
    Lin AY,Wong WD,Shia J, et al. Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis. 2008; 23: 243249.
  • 31
    Chapet O,Romestaing P,Mornex F, et al. Preoperative radiotherapy for rectal adenocarcinoma: which are strong prognostic factors? Int J Radiat Oncol Biol Phys. 2005; 61: 13711377.
  • 32
    Gosens MJ,van Krieken JH,Marijnen CA, et al. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. Clin Gastroenterol Hepatol. 2007; 5: 9971003.